Friday broker round-up - UPDATE
13th Jan 2012 11:19
Vodafone: Nomura upgrades to buy. Bunzl: UBS cuts to neutral from buy. RSA Insurance: Citi cuts to neutral from buy. BT Group: Nomura upgrades to buy from reduce. RBS: Seymour Price upgrades to buy from reduce. BG Group: JP Morgan raises price target to 1,900p from 1,455p. Tesco: Credit Suiss
Read moreBroker tips: Tesco, Smith & Nephew, Spectris
13th Jan 2012 10:28
Analysts at Credit Suisse seem to be amongst those who were left somewhat traumatised by the carnage in retailer Tesco's share price yesterday. Credit Suisse has revised down their Tesco earnings estimates by 13% for 2012/13E (slightly less thereafter), which is very sizeable in the context of Tes
Read moreBroker snap: Bioventus JV a sensibile move for Smith & Nephew, says Investec
13th Jan 2012 09:52
Investec may have made downgrades to its forecasts for Smith & Nephew, but the broker has maintained its buy rating on the medical devices giant. The group agreed last week to form a joint venture (JV) with Essex Woodlands, a specialist healthcare growth equity and venture capital firm, that will s
Read moreSector movers: ARM has more tricks up its sleeve
5th Jan 2012 13:40
Chip designer ARM Holdings leads the Technology sector higher after a bullish research note from UBS. The Swiss bank reckons ARM's fourth-quarter revenues could be up to 6% higher than the market is expecting. UBS analyst Gareth Jenkins also took a look at other potential catalysts for share price
Read moreLondon close: Footsie follows Wall Street lower
4th Jan 2012 17:12
Having spent most of the day seeking direction, UK investors took the hint from their US counterparts and banked some of yesterday's heavy gains. Fashion chain Next was one of the day's biggest fallers, after a cautious trading statement. The company said "despite a good final week before Christma
Read moreLondon midday: Footsie back to square one
4th Jan 2012 10:38
UK equities are seeking direction after a morning in which the Footsie moved in a narrow band ranging from 5689 to 5720. Fashion chain Next is a drag on the index, after a cautious trading statement. The company said "despite a good final week before Christmas, November and December sales were disa
Read moreLondon open: Retailers caned after Next disappoints
4th Jan 2012 08:38
Footsie has defied expectations of a soft start and has crept above the 5,700 barrier, helped by continuing demand for resource stocks. Fashion chain Next is a drag on the index, however, after a cautious trading statement. The company said"despite a good final week before Christmas, November and D
Read moreLondon pre-open: Stocks to open lower after yesterday's boom
4th Jan 2012 07:35
Stocks are set to start the day lower as they settle down following Tuesday's strong trading. City sources predict the FTSE 100 will open down 24 points from yesterday's close of 5,700. Pizza delivery firm Domino's Pizza saw a slow-down in year-on-year like-for-like sales (LFL) growth in the fina
Read moreSmith and Nephew hives off US Biologics arm
4th Jan 2012 07:19
Smith and Nephew, the medical technology business, has agreed to form a joint venture with Essex Woodlands, a specialist healthcare growth equity and venture capital firm, that will see it transfer the bulk of its US biologics team and Clinical Therapies business to the new firm. The new entity, ca
Read moreWednesday tips round-up: Smith & Nephew, AstraZeneca
21st Dec 2011 06:52
The Times's Tempus column looks at medical supplies firm Smith and Nephew which was once a perennial takeover target. After a re-organisation by its new Chief Executive the group is now focused on growth in the developing markets of China and India. A key metric for the firm though is how much ele
Read moreSmith & Nephew sees shares fall on leaked details
5th Dec 2011 12:49
Medical technology business Smith & Nephew lost 4p on its share price after it was revealed that US medical programme, Medicare, is refusing to pay for patients to stay in hospital for orthopedic operations in 11 states unless the treatment is reviewed and deemed necessary. In a letter between the
Read moreThursday broker round-up - UPDATE
24th Nov 2011 09:48
Weir: Peel Hunt upgrades from hold to buy, target cut from 2,100p to 2,000p. Weir: Investec maintains buy rating and 2,250p target. Compass: Panmure Gordon raises target from 643p to 658p, buy rating unchanged. Smith & Nephew: Panmure Gordon cuts target from 750p to 640p, buy rating kept. Dixons
Read moreLondon close: Footsie extends losing streak
22nd Nov 2011 16:42
After spending almost all of the day in the blue and threatening to end a six-day losing streak, Footsie tumbled at the death to extend its miserable sequence. Disappointing third quarter gross domestic product data from the US played a part in London's late swoon. The second estimate for third qu
Read moreLondon midday: Miners on the rise, defence stocks down on US fears
22nd Nov 2011 12:23
London's blue chip index held on to gains in morning trade, recovering after a six-day sell-off. While markets are still concerned with the ongoing troubles in the Eurozone, fears over the credit rating of the US eased after Standard & Poor's and Moody's reiterated their ratings last night. Neverth
Read moreTuesday broker round-up - UPDATE
22nd Nov 2011 09:34
British Land: Bank of America-Merrill Lynch upgrades to buy from neutral. Centrica: Goldman Sachs keeps at Conviction Buy. Smith&Nephew: Citi cuts target to 492p from 507p, keeps at sell. Smith&Nephew: Citi reiterates neutral. Thomas Cook: Evolution Securities downgrades from neutral to sell, t
Read more